We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App





LGC Clinical Diagnostics Demonstrates How Labs Can Enhance QC Efficiencies at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 06 Feb 2023
Print article
Image: Multichem is a class leading, third-party, test-consolidated QC product range (Photo courtesy of LGC)
Image: Multichem is a class leading, third-party, test-consolidated QC product range (Photo courtesy of LGC)

LGC Clinical Diagnostics (Middlesex, UK) is attending Medlab Middle East 2023 where it is demonstrating how laboratories can enhance their quality control (QC) efficiencies through automated processes with independent QC and QC data management.

Under LGC Clinical Diagnostics Group, the company’s booth at this year’s Medlab Middle East is representing the combined brands: Maine Standards, SeraCare, Technopath Clinical Diagnostics, and The Native Antigen Company. LGC is presenting its comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions and component materials with representatives from each company available to answer all the questions of visitors at its booth.

At Medlab Middle East 2023, LGC is showcasing Technopath’s total QC solution, Multichem QC and IAMQC software that provide clinical laboratories with significant cost, handling and time savings, whilst delivering higher confidence in analytical testing methods. With an extensive list of analytes included in the Multichem range of QC products, choice and flexibility are guaranteed for all customers. The third party QC products include General Clinical Chemistry, Immunoproteins, Immunoassay, Cardiac, Urine Chemistry, Infectious Disease, Diabetes and other Esoteric controls. The controls are offered in assayed and unassayed formats. Technopath’s human based control matrix offers unrivalled test consolidation through increased control stability and diminished matrix effects. Together, these aspects of control manufacture offer greater control efficiencies without compromising compliance or confidence in patient results.

LGC is also demonstrating the IAMQC Software from Technopath that provides laboratory managers and technologists with a range of QC software tools to analyze their QC results in real-time. IAMQC Software tools allow users to automate, centralize, standardize and improve QC processes in a laboratory setting. A combination of modules satisfies the varying levels of QC requirements in individual laboratories and is easily tailored to meet different QC management expectations. This also includes the new IAMQC Infinity that incorporates all the functionality of IAMQC Peer, Daily and Expert in one application. The powerful cloud based software designed to exactly meet specific QC solution needs has a feature-based interface that allows the laboratory to build their custom solution and then to seamlessly add in further sophisticated features as and when needed.

Related Links:
LGC

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.